Group One Trading
NRXP icon

Group One Trading’s NRX Pharmaceuticals NRXP Stock Holding History

Group One Trading’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$852 – 8199
2026
Q1 		$852 Buy
400
+300
+300% +$606 ﹤0.01% 7244
2025
Q4 		$271 Sell
100
-300
-75% -$805 ﹤0.01% 7861
2025
Q3 		$1.32K Buy
400
+100
+33% +$286 ﹤0.01% 8007
2025
Q2 		$978 Sell
300
-2,200
-88% -$5.51K ﹤0.01% 7569
2025
Q1 		$5.13K Buy
+2,500
New +$7.04K ﹤0.01% 6632
2024
Q2 		– Sell
-10
Closed -$47 – 7232
2024
Q1 		$47 Buy
+10
New +$46 ﹤0.01% 6864
2023
Q3 		– Sell
-820
Closed -$3.96K – 8075
2023
Q2 		$3.96K Buy
820
+10
+1% +$60 ﹤0.01% 6819
2023
Q1 		$5.34K Sell
810
-40
-5% -$405 ﹤0.01% 6250
2022
Q4 		$9.44K Sell
850
-10
-1% -$101 ﹤0.01% 6052
2022
Q3 		$6K Sell
860
-1,700
-66% -$11.5K ﹤0.01% 6757
2022
Q2 		$15K Sell
2,560
-3,540
-58% -$46.5K ﹤0.01% 6515
2022
Q1 		$149K Buy
6,100
+770
+14% +$25K ﹤0.01% 5103
2021
Q4 		$255K Buy
5,330
+4,090
+330% +$295K ﹤0.01% 4835
2021
Q3 		$115K Buy
+1,240
New +$161K ﹤0.01% 5770

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading's NRXP Position: Q2 2026 in Review

Group One Trading sold out of NRX Pharmaceuticals (NRXP) in Q2 2026, closing a stake of 737 shares — an estimated $2.43K sold.

Group One Trading first reported a position in NRXP in Q3 2021 and held it in 14 quarters. The position peaked at $104K in Q2 2022. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Group One Trading reported no remaining NRX Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 737 NRX Pharmaceuticals shares in Q2 2026, an estimated $2.43K.
  • Group One Trading first reported a position in NRX Pharmaceuticals in Q3 2021 and held it in 14 quarters.
  • Group One Trading's NRX Pharmaceuticals position peaked at $104K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.